Patient Perspective: Fighting the Good Fight with Hemifacial Spasm
Danielle Clements The FPA’s 35th Anniversary Special Correspondent “Can anyone see it happening? Is it worse than yesterday? How noticeable is it? Don’t smile, it looks worse when you smile…“
Advancing Facial Pain Treatment with the Power of Clinical Trials and Research
Advancements in Drug Development Medications used to manage trigeminal neuralgia (TN), such as carbamazepine, oxcarbazepine, lamotrigine, and lacosamide, were initially developed for epilepsy and later adapted for TN. However, there
Transposition versus Interposition in Microvascular Decompression for Trigeminal Neuralgia
Colby Joncas, BS and Raymond F. Sekula, Jr., MD There has been a great deal of discussion recently about the “best” way to perform a microvascular decompression (MVD) for treatingFacial Pain Association and the University of Minnesota Collaborate to Host a Conference Giving Patients Access to Experts in Neuropathic Facial Pain Treatment, Research, and Advocacy
FOR IMMEDIATE RELEASE Contact: Sarah Winner Marketing, Communications, and Events Manager [email protected] May 7, 2025 Facial Pain Association and the University of Minnesota Collaborate to Host a Conference Giving Patients
Celebrating 35 Years — Building the Future Together
This year, the Facial Pain Association is proud to celebrate 35 years of dedication to our mission — improving the lives of those affected by facial pain through support, education,
